Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

Hartley HE, Fong FC, Gabriel AS, Stevenson LK, Beckett E, Allinson LM, Goodman A, Potts A, Whittle E, Barford R, Lamparelli A, Herd F, Mazzocco K, Pezzolo A, Morini M, Ardito M, Eva A, Ognibene M, Fischer M, Ackermann S, Rosswog C, Hero B, Smith GR, Unsworth AA, McCorkindale M, George SL, Tall J, Molenaar JJ, Matser Y, Langenberg K, Tytgat G, Noguera R, Berbegall AP, de Mora JF, Combaret V, Pierron G, Mühlethaler-Mottet A, Schoumans J, Tchinda J, Banzola I, Jeison M, Hameiri-Grossman M, Beiske KH, Auger N, Van Roy N, Basta NO, McNally RJQ, Taschner-Mandl S, Papadakis V, Di Cataldo A, Wheeler K, Bermúdez JD, Beck-Popovic M, Segura V, Canete A, Schleiermacher G, Tweddle DA

Open source

DOI
10.1200/po-26-00045
Published
2026 Jul
Container
JCO precision oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1200/po-26-00045,
  title = {Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.},
  author = {Hartley HE and Fong FC and Gabriel AS and Stevenson LK and Beckett E and Allinson LM and Goodman A and Potts A and Whittle E and Barford R and Lamparelli A and Herd F and Mazzocco K and Pezzolo A and Morini M and Ardito M and Eva A and Ognibene M and Fischer M and Ackermann S and Rosswog C and Hero B and Smith GR and Unsworth AA and McCorkindale M and George SL and Tall J and Molenaar JJ and Matser Y and Langenberg K and Tytgat G and Noguera R and Berbegall AP and de Mora JF and Combaret V and Pierron G and Mühlethaler-Mottet A and Schoumans J and Tchinda J and Banzola I and Jeison M and Hameiri-Grossman M and Beiske KH and Auger N and Van Roy N and Basta NO and McNally RJQ and Taschner-Mandl S and Papadakis V and Di Cataldo A and Wheeler K and Bermúdez JD and Beck-Popovic M and Segura V and Canete A and Schleiermacher G and Tweddle DA},
  year = {2026},
  journal = {JCO precision oncology},
  doi = {10.1200/po-26-00045},
  url = {https://doi.org/10.1200/po-26-00045}
}

RIS

TY  - JOUR
TI  - Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.
AU  - Hartley HE
AU  - Fong FC
AU  - Gabriel AS
AU  - Stevenson LK
AU  - Beckett E
AU  - Allinson LM
AU  - Goodman A
AU  - Potts A
AU  - Whittle E
AU  - Barford R
AU  - Lamparelli A
AU  - Herd F
AU  - Mazzocco K
AU  - Pezzolo A
AU  - Morini M
AU  - Ardito M
AU  - Eva A
AU  - Ognibene M
AU  - Fischer M
AU  - Ackermann S
AU  - Rosswog C
AU  - Hero B
AU  - Smith GR
AU  - Unsworth AA
AU  - McCorkindale M
AU  - George SL
AU  - Tall J
AU  - Molenaar JJ
AU  - Matser Y
AU  - Langenberg K
AU  - Tytgat G
AU  - Noguera R
AU  - Berbegall AP
AU  - de Mora JF
AU  - Combaret V
AU  - Pierron G
AU  - Mühlethaler-Mottet A
AU  - Schoumans J
AU  - Tchinda J
AU  - Banzola I
AU  - Jeison M
AU  - Hameiri-Grossman M
AU  - Beiske KH
AU  - Auger N
AU  - Van Roy N
AU  - Basta NO
AU  - McNally RJQ
AU  - Taschner-Mandl S
AU  - Papadakis V
AU  - Di Cataldo A
AU  - Wheeler K
AU  - Bermúdez JD
AU  - Beck-Popovic M
AU  - Segura V
AU  - Canete A
AU  - Schleiermacher G
AU  - Tweddle DA
PY  - 2026
JO  - JCO precision oncology
DO  - 10.1200/po-26-00045
UR  - https://doi.org/10.1200/po-26-00045
ER  -

APA

HE, H., FC, F., AS, G., LK, S., E, B., LM, A., A, G., A, P., E, W., R, B., A, L., F, H., K, M., A, P., M, M., M, A., A, E., M, O., M, F., S, A., C, R., B, H., GR, S., AA, U., M, M., SL, G., J, T., JJ, M., Y, M., K, L., G, T., R, N., AP, B., JF, D. M., V, C., G, P., A, M., J, S., J, T., I, B., M, J., M, H., KH, B., N, A., N, V. R., NO, B., RJQ, M., S, T., V, P., A, D. C., K, W., JD, B., M, B., V, S., A, C., G, S., & DA, T. (2026). Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.. JCO precision oncology. https://doi.org/10.1200/po-26-00045

Source records